AVTX-803
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AVTX-803, covering 2024-11-01 to 2024-11-01. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II [Phase 3]